integr
myelin
sheath
depend
upon
normal
function
myelinform
oligodendrocyt
central
nervou
system
cn
schwann
cell
peripher
nervou
system
pn
well
viabil
axon
ensheath
neuron
death
inevit
lead
degener
axon
secondari
degener
myelin
surround
primari
diseas
myelin
myelinform
cell
result
multitud
caus
includ
autoimmun
viral
infect
genet
defect
toxic
agent
malnutrit
mechan
trauma
comprehens
descript
clinic
featur
patholog
pathogenesi
diseas
describ
chapter
avail
special
book
lazzarini
love
et
al
ropper
samuel
histor
perspect
neurochemistri
myelin
diseas
reader
refer
book
myelin
edit
pierr
morel
plenum
press
myelin
defici
result
failur
synthesi
develop
myelin
breakdown
format
failur
synthesi
normal
myelin
protein
lipid
usual
refer
hypomyelin
dysmyelin
myelin
form
initi
becom
progress
vulner
degener
age
due
accumul
metabol
intermedi
diseas
result
loss
normal
myelin
form
ie
demyelin
subdivid
primari
secondari
categori
basi
morpholog
observ
primari
demyelin
involv
destruct
myelin
rel
spare
axon
wherea
secondari
demyelin
includ
disord
myelin
involv
damag
neuron
axon
occur
howev
recent
year
becom
increasingli
appar
diseas
classifi
primari
demyelin
may
involv
injuri
axon
origin
thought
axon
damag
could
caus
inflamm
loss
trophic
support
provid
myelin
cell
axon
topic
describ
detail
section
multipl
sclerosi
acquir
inherit
peripher
neuropathi
pronounc
biochem
chang
associ
cn
demyelin
occur
white
matter
mark
increas
water
content
decreas
myelin
protein
lipid
andor
appear
lipid
protein
cholesterol
ester
glial
fibrillari
acid
protein
gfap
particularli
noteworthi
regard
lipid
dramat
decreas
galactocerebrosid
ethanolamin
plasmalogen
cholesterol
enrich
myelin
membran
see
ch
major
structur
protein
cn
myelin
myelin
basic
protein
mbp
proteolipid
protein
plp
also
invari
decreas
chang
explain
breakdown
gradual
loss
myelin
rel
rich
solid
replac
extracellular
fluid
astrocyt
inflammatori
cell
hydrat
rel
lipidpoor
free
myelinspecif
constitu
frequent
appear
cholesterol
ester
demyelin
diseas
relat
fact
cholesterol
readili
degrad
esterifi
phagocyt
often
remain
site
lesion
time
sinc
cholesterol
ester
essenti
absent
normal
matur
brain
presenc
myelin
disord
indic
recent
phagocytosi
myelin
cn
gfap
specif
astrocyt
increas
protein
demyelin
due
reactiv
astrocytosi
see
ch
magnitud
chang
mention
vari
consider
diseas
diseas
specimen
specimen
diseas
depend
sever
locat
durat
activ
patholog
process
nervou
system
damag
acquir
demyelin
diseas
select
myelin
myelinform
cell
axon
also
often
affect
acquir
immunemedi
diseas
involv
either
cn
pn
myelin
acquir
infecti
disord
lesion
dissemin
character
perivenular
demyelin
inflamm
macrophagemedi
phagocytosi
myelin
lipid
protein
rel
spare
axon
often
diseas
begin
third
fourth
decad
neurolog
dysfunct
blur
doubl
vision
slur
speech
weak
limb
sensori
deficit
paresthesia
compston
cole
common
initi
cours
refer
relapsingremit
ms
character
acut
episod
one
symptom
follow
subsequ
recoveri
time
improv
attack
may
incomplet
relapsingremit
cours
may
evolv
one
increas
progress
disabl
term
secondari
progress
ms
approxim
patient
develop
form
diseas
begin
slowli
progress
process
term
primari
progress
ms
patient
aggress
cours
even
lead
death
short
period
neuromyel
optica
devic
diseas
demyelin
diseas
character
transvers
myeliti
optic
neuriti
consid
subtyp
ms
recent
antibodi
aquaporin
waterchannel
protein
astrocyt
identifi
patient
diseas
see
box
astrocyt
appear
primari
autoimmun
target
oligodendrocyt
myelin
secondari
target
therefor
neuromyel
optica
current
consid
distinct
entiti
diagnosi
ms
depend
evid
cn
involv
separ
time
space
ie
must
evid
two
area
cn
involv
histori
involv
occur
two
differ
time
without
identifi
caus
diagnosi
made
sole
clinic
criteria
result
long
delay
diagnosi
treatment
current
criteria
permit
diagnosi
made
less
clinic
evid
specif
featur
present
magnet
reson
imag
mri
polman
et
al
result
cerebrospin
fluid
analysi
also
vi
inherit
neurodegen
diseas
use
support
diagnosi
ms
case
clinic
imag
data
suffici
varieti
mri
imag
protocol
use
diagnosi
monitor
patient
ms
fox
mri
sensit
sequenc
identif
lesion
brain
ms
patient
specif
inflammatori
demyelin
ischem
necrosi
result
increas
signal
imag
also
distinguish
new
old
lesion
imag
administr
gadolinium
identifi
new
lesion
bloodbrain
barrier
compromis
serial
studi
patient
earli
relapsingremit
ms
shown
first
event
develop
new
ms
lesion
appear
gadoliniumenhanc
lesion
occur
period
clinic
stabil
mani
patient
newer
imag
techniqu
magnet
reson
spectroscopi
magnet
transfer
ratio
diffus
tensor
imag
provid
addit
character
lesion
time
correl
mri
postmortem
brain
histopatholog
eg
fisher
et
al
valid
interpret
lesion
identifi
differ
techniqu
help
focu
ongo
research
ms
lesion
occur
part
cn
area
predilect
periventricular
white
matter
subpial
white
matter
brainstem
spinal
cord
white
matter
lesion
typic
sharpli
demarc
surround
tissu
fig
microscop
examin
show
loss
myelin
rel
preserv
axon
inflammatori
infiltr
compos
lymphocyt
myeloid
lineag
cell
macrophag
microglia
tlymphocyt
predomin
blymphocyt
plasma
cell
also
present
lesion
commonli
origin
around
venul
alway
case
lucchinetti
et
al
activ
whitematt
lesion
classifi
activ
chronic
activ
chronic
inact
base
upon
immunohistochem
stain
pattern
use
antibodi
myelin
protein
myeloid
cell
activ
lesion
hypercellular
due
inflammatori
infiltr
wherea
chronic
lesion
hypocellular
due
rel
pauciti
inflamm
oligodendrocyt
loss
detail
immunocytochem
studi
activ
lesion
biopsi
autopsi
specimen
suggest
ms
lesion
subdivid
four
differ
pattern
tcellmedi
demyelin
antibodymedi
demyelin
primari
oligodendrocyt
death
without
apoptosi
lucchinetti
et
al
recent
report
describ
activ
ms
lesion
area
myelin
phagocytosi
oligodendrocyt
loss
absenc
lymphocyt
inflamm
support
idea
primari
oligodendrocyt
degener
may
preced
inflammatori
respons
henderson
et
al
increas
recognit
cerebr
cortic
demyelin
ms
role
patholog
may
play
role
autoantibodi
aquaporin
neuromyel
optica
first
suggest
studi
human
sera
react
mous
tissu
section
sera
patient
nmo
show
pattern
immunoreact
highlight
cn
microvessel
pia
lennon
et
al
pattern
immunoreact
kidney
stomach
suggest
target
antigen
proven
case
lennon
et
al
studi
tissu
nmo
patient
show
loss
immunoreact
complement
deposit
lesion
inflammatori
demyelin
uninvolv
tissu
time
known
predomin
water
channel
brain
role
brain
edema
format
respons
varieti
etiolog
possibl
involv
neuroinflamm
never
investig
sever
group
explor
pathogen
role
antibodi
rodent
model
see
li
et
al
refer
studi
show
administr
antibodi
anim
eae
along
complement
anim
produc
patholog
characterist
nmo
eae
induc
knockout
mice
anim
attenu
symptom
cn
inflamm
compar
wildtyp
control
group
went
perform
systemat
explor
mechan
defici
protect
anim
inflammatori
patholog
eae
li
et
al
major
differ
two
group
knockout
mice
show
decreas
inflammatori
respons
intracerebr
inject
lipopolysaccharid
lp
vitro
analysi
microgliafre
astrocyt
cultur
show
lp
induc
secret
tnfalpha
medium
reduc
knockout
anim
compar
control
transfect
studi
demonstr
cytokin
secret
directli
relat
express
cell
recent
data
provid
new
hypothes
investig
role
water
permeabl
function
astrocyt
neuroinflamm
neurolog
dysfunct
includ
cognit
deficit
experienc
ms
patient
sever
patholog
classif
cortic
lesion
propos
one
scheme
describ
three
type
peterson
et
al
type
lesion
present
leukocort
junction
involv
cortex
subcort
white
matter
type
ii
lesion
locat
entir
within
cortex
typic
center
blood
vessel
type
iii
lesion
appear
begin
pial
surfac
extend
superfici
layer
cortex
singl
type
iii
lesion
involv
sever
gyri
total
lesion
area
quit
extens
cortic
demyelin
occur
without
signific
influx
hematogen
leukocyt
peterson
et
al
compar
white
matter
lesion
fewer
lymphocyt
perivascular
cuff
phagocyt
macrophag
extrem
rare
mani
activ
microglia
present
often
dens
lesion
edg
cortic
lesion
detect
convent
mri
modal
although
oligodendrocyt
myelin
appear
primari
target
ms
neuron
also
damag
diseas
fact
axon
transect
consid
patholog
underli
perman
disabl
ms
patient
axon
transect
degener
occur
set
acut
inflammatori
demyelin
consequ
chronic
demyelin
frequenc
transect
axon
white
matter
lesion
correl
degre
inflamm
activ
highli
inflam
lesion
contain
transect
axon
per
mm
tissu
edg
chronic
activ
lesion
contain
transect
axon
per
mm
tissu
wherea
core
chronic
lesion
contain
averag
transect
axon
per
mm
tissu
trapp
et
al
cortic
lesion
littl
inflamm
contain
transect
neurit
axon
dendrit
number
seen
activ
white
matter
lesion
peterson
et
al
identif
apoptot
neuron
cortic
lesion
confirm
cortic
demyelin
lethal
neuron
axon
loss
parenchym
atrophi
also
featur
chronic
demyelin
brain
trapp
nave
fig
stage
usual
minim
evid
inflamm
differ
mechan
may
respons
axon
degener
studi
anim
model
suggest
longterm
axon
surviv
requir
trophic
support
oligodendrocyt
exampl
remov
myelin
protein
myelin
associ
glycoprotein
mag
nucleotid
cnp
mice
result
lateonset
axon
degener
without
signific
myelin
patholog
data
demonstr
normal
myelin
requir
longterm
axon
surviv
signal
mechan
myelin
oligodendrocyt
support
axon
unknown
understand
mechan
could
aid
develop
neuroprotect
therapi
ms
patient
import
analysi
repeat
mri
ms
patient
show
brain
atrophi
one
reliabl
predictor
clinic
diseas
progress
biochemistri
demyelin
ms
review
detail
cuzner
norton
affect
area
ms
white
matter
exhibit
expect
decreas
myelin
constitu
buildup
cholesterol
ester
exampl
polyacrylamid
gel
electrophoresi
homogen
macroscop
normal
appear
white
matter
outer
periplaqu
inner
periplaqu
plaqu
show
expect
declin
mbp
plp
go
normalappear
white
matter
center
plaqu
chronic
acut
lesion
fig
virtual
absenc
myelin
protein
center
chronic
plaqu
accumul
gfap
indic
astrogliosi
fig
plaqu
acut
lesion
complet
demyelin
indic
presenc
mbp
plp
accumul
gfap
fig
acut
plaqu
contain
albumin
result
breakdown
bloodbrain
barrier
number
biochem
studi
indic
myelin
constitu
significantli
reduc
even
area
macroscop
normalappear
white
matter
ms
brain
comparison
control
white
matter
probabl
explain
presenc
microles
throughout
affect
brain
recent
research
involv
biochemistri
ms
focus
molecular
mechan
damag
acut
lesion
chronic
demyelin
axon
trapp
sti
inflammatori
microenviron
acut
lesion
contain
varieti
substanc
proteolyt
enzym
cytokin
oxid
product
free
radic
directli
injur
cell
substanc
present
inflammatori
microenviron
induc
signal
transduct
event
ultim
result
injuri
affect
migrat
cell
involv
damag
repair
mechan
neurodegener
chronic
lesion
propos
repres
imbal
axon
energi
figur
coron
slice
brain
patient
die
ms
demyelin
plaqu
clearli
visibl
periventricular
subcort
white
matter
larg
arrow
periventricular
lesion
show
focal
cavit
consist
axon
loss
small
plaqu
also
observ
boundari
gray
white
matter
small
arrow
gener
atrophi
often
seen
brain
ms
patient
illustr
enlarg
later
ventricl
photograph
courtesi
c
rain
vi
inherit
neurodegen
diseas
demand
limit
energi
suppli
trapp
sti
nerv
conduct
nonmyelin
axon
requir
atp
myelin
axon
recent
analysi
ms
brain
show
express
nuclear
encod
mitochondri
gene
reduc
nonles
cortex
impli
impair
mitochondri
energi
product
ms
brain
impair
atp
product
axon
result
alter
ionic
gradient
includ
accumul
axoplasm
ca
activ
ca
depend
proteolyt
enzym
damag
axon
treatment
patient
ms
includ
manag
symptom
attempt
slow
cours
diseas
compston
cole
sever
class
therapi
approv
patient
relapsingremit
ms
consid
diseas
modifi
believ
affect
inflammationmedi
injuri
betainterferon
approv
ms
therapi
mani
immunomodulatori
effect
mechan
treatment
reduc
number
relaps
unknown
although
interferon
treatment
delay
diseas
progress
stop
glatiram
acet
synthet
random
polym
compos
lalanin
lglutam
acid
llysin
ltyrosin
believ
block
antigen
present
promot
antiinflammatori
respons
mitoxantron
synthet
antineoplast
anthrocenedion
caus
immunosuppress
inhibit
prolifer
band
tcell
macrophag
although
efficaci
reduc
relaps
progress
disabl
risk
cardiotox
secondari
leukemia
limit
use
anoth
therapeut
approach
inhibit
migrat
tcell
across
bloodbrain
barrier
natalizumab
human
monoclon
antibodi
direct
alpha
block
function
natalizumab
highli
effect
control
relaps
reduc
appear
new
lesion
mri
unfortun
treatment
natalizumab
monoclon
antibodi
interfer
leukocyt
function
result
progress
multifoc
leukoencephalopathi
pml
fatal
viralmedi
demyelin
diseas
see
current
drug
approv
subset
patient
refractori
therapi
use
requir
close
surveil
develop
pml
recent
drug
approv
ms
fingolimod
fingolimod
given
oral
contrast
agent
requir
inject
intraven
infus
induc
intern
type
receptor
lymphocyt
result
sequestr
lymphocyt
peripher
lymphoid
organ
longterm
efficaci
fingolimod
still
investig
altern
approach
therapi
involv
repair
stimul
remyelin
promot
surviv
regener
axon
discuss
greater
detail
end
chapter
despit
intens
research
mani
decad
caus
ms
still
unknown
follow
paragraph
summar
exist
data
suscept
develop
ms
serv
formul
hypothes
etiolog
end
perspect
reconsider
exist
knowledg
might
util
formul
new
hypothes
futur
research
descript
clinic
diseas
entiti
characterist
ms
first
clearli
record
earli
centuri
compston
cole
ms
first
defin
clinicalpatholog
entiti
charcot
epidemiolog
survey
centuri
show
ms
preval
northern
europ
north
america
africa
asia
correspondingli
ms
preval
among
caucasian
incid
ms
document
worldwid
recent
analys
larg
clinic
registri
ms
patient
demonstr
clinic
cours
ms
quit
variabl
earli
stage
diseas
later
stage
uniform
rate
progress
chronolog
age
perman
disabl
mileston
achiev
see
compston
sever
type
evid
indic
environment
factor
influenc
risk
develop
ms
compston
cole
studi
geograph
migrat
show
risk
ms
highest
among
peopl
live
highpreval
area
prior
puberti
addit
report
epidem
cluster
increas
ms
incid
possibl
environment
exposur
includ
infect
nutrit
factor
chemic
toxic
among
viral
etiolog
subject
intens
investig
candid
virus
includ
measl
rubella
mump
herp
virus
includ
epsteinbarr
viru
herp
simplex
viru
varicella
zoster
viru
human
herp
viru
much
interest
base
upon
risk
acut
dissemin
encephalomyel
follow
viral
infect
vaccin
preval
seroposit
certain
virus
epsteinbarr
viru
among
ms
patient
although
evid
risk
ms
attribut
classic
mendelian
genet
inherit
multipl
studi
provid
data
support
genet
compon
suscept
diseas
compston
cole
first
differ
preval
ms
among
ethnic
group
second
welldocu
increas
risk
among
firstdegre
rel
individu
diseas
specif
risk
ms
monozygot
twin
compar
among
fratern
twin
recent
genomewid
analysi
singlenucleotid
polymorph
identifi
number
genet
loci
associ
increas
risk
ms
among
gener
popul
australia
new
zealand
multipl
sclerosi
genet
consortium
anzgen
de
jager
et
al
mani
polymorph
map
gene
genet
loci
associ
immun
regul
strongest
associ
gene
chromosom
account
genet
suscept
ms
increas
number
genet
loci
implic
suscept
ms
indic
ms
genet
diseas
complex
genet
disord
multipl
interact
polymorph
gene
low
penetr
exert
small
effect
overal
diseas
risk
ch
inflammatori
histopatholog
demyelin
lesion
ms
abil
myelin
antigen
induc
experiment
allerg
encephalomyel
respons
patient
relapsingremit
ms
antiinflammatori
treatment
provid
basi
hypothesi
ms
autoimmun
diseas
aris
set
environment
genet
risk
factor
autoimmun
respons
could
induc
molecular
mimicri
infecti
agent
effort
identifi
singl
respons
agent
unsuccess
may
sever
myelin
antigen
play
role
ms
rel
import
differ
antigen
vari
among
individu
depend
immunogenet
background
environment
factor
encount
life
furthermor
possibl
ms
patient
autoantibodi
recogn
complex
two
myelin
antigen
case
patient
syndrom
investig
preced
paragraph
summar
evid
role
multipl
factor
develop
ms
complex
led
author
question
whether
longheld
hypothes
base
upon
evid
reevalu
new
hypothes
propos
investig
exampl
recent
research
epidemiolog
compston
patholog
henderson
et
al
ms
rais
possibl
ms
could
primari
degen
diseas
oligodendrocyt
secondari
immun
inflammatori
tissu
respons
research
immunohistochemistri
activ
demyelin
lesion
suggest
differ
pathogenet
mechan
give
rise
clinic
phenotyp
lucchinetti
et
al
fortun
technolog
biochem
analys
includ
genom
rna
express
profil
proteom
advanc
rapidli
research
small
histolog
defin
region
within
ms
lesion
frozen
even
fix
archiv
tissu
becom
feasibl
treatment
test
use
ms
patient
select
base
upon
efficaci
anim
model
primari
etiolog
ms
unknown
model
employ
research
develop
replic
differ
aspect
ms
patholog
singl
model
replic
diseas
manifest
human
denic
et
al
therefor
data
anim
model
must
critic
evalu
view
result
gener
ms
patient
number
natur
occur
viral
diseas
human
anim
caus
demyelin
fazakerley
walker
diseas
provid
basi
hypothesi
ms
may
initi
viral
infect
best
exampl
human
progress
multifoc
leukoencephalopathi
discuss
subacut
scleros
panenceph
caus
measl
viru
canin
distemp
viru
caus
demyelin
diseas
lesion
dog
brain
show
strong
inflammatori
respons
similar
acut
dissemin
encephalomyel
human
discuss
visna
slowli
progress
demyelin
diseas
sheep
caus
retroviru
model
ms
use
intracerebr
inject
mice
neurotrop
virus
jhm
neurotrop
strain
coronaviru
mous
hepat
viru
infect
oligodendrocyt
produc
acut
chronic
inflammatori
demyelin
rodent
bergmann
et
al
theiler
viru
picornaviru
infect
mani
neural
cell
type
induc
chronic
encephalomyel
sato
et
al
investig
anim
model
reveal
sever
mechan
viral
infect
caus
demyelin
includ
direct
infect
oligodendrocyt
result
cell
death
virusspecif
inflammatori
respons
cytokin
immun
mediat
damag
oligodendrocyt
myelin
indirectli
bystand
effect
activ
immun
respons
direct
compon
oligodendrocytesmyelin
molecular
mimicri
epitop
spread
molecular
mimicri
occur
viral
antigen
structur
homolog
myelinoligodendrocyt
compon
result
crossreact
epitop
spread
result
host
immun
cell
process
myelinoligodendrocyt
antigen
releas
follow
tissu
injuri
experiment
allerg
encephalomyel
eae
anim
model
use
studi
autoimmun
hypothesi
ms
eae
model
initi
identifi
effort
understand
caus
encephalomyel
inocul
patient
pasteur
rabi
vaccin
prepar
virusinfect
nervou
tissu
note
even
control
experiment
anim
inocul
uninfect
neural
tissu
develop
encephalomyel
sinc
discoveri
eae
induc
number
speci
varieti
techniqu
includ
model
repres
acut
chronic
relaps
aspect
inflammatori
demyelin
diseas
usual
eae
induc
immun
myelin
protein
peptid
notabl
mbp
plp
myelinoligodendrocyt
glycoprotein
mog
classic
form
diseas
mediat
primarili
major
histocompat
complex
mhc
class
ii
restrict
tcell
stimul
peripheri
enter
cn
transfer
tcell
naiv
anim
induc
diseas
although
data
document
import
lymphocyt
eae
induct
studi
ms
tissu
show
tcell
predomin
lymphocyt
popul
consider
variat
suscept
variou
anim
variat
larg
due
genet
background
especi
mhc
gene
observ
relev
genet
associ
mhc
gene
identifi
ms
patient
australia
new
zealand
multipl
sclerosi
genet
consortium
anzgen
de
jager
et
al
characterist
compon
eae
lesion
perivascular
inflamm
extent
demyelin
vari
speci
ident
immunogen
use
induc
diseas
evid
studi
eae
rat
mous
indic
activ
tcell
regardless
specif
cross
bloodbrain
barrier
enter
nervou
system
tcell
encount
antigen
cell
activ
begin
product
proinflammatori
cytokin
gammainterferon
tumor
necrosi
factoralpha
turn
activ
endotheli
cell
upregul
cell
adhes
molecul
see
ch
promot
entri
addit
inflammatori
cell
cn
outcom
process
least
anim
myelin
damag
actual
effector
mechan
myelin
damag
includ
direct
toxic
effect
tumor
necrosi
factoralpha
nitric
oxid
oligodendrocyt
damag
mediat
macrophag
microgli
cell
latter
possibl
enhanc
presenc
antibodi
bind
myelin
provid
ligand
activ
monocyt
inde
demyelin
associ
eae
sever
anim
includ
rat
mous
marmoset
increas
presenc
antibodi
surfac
compon
myelin
galactocerebrosid
mog
fact
immun
rodent
mog
alon
shown
induc
relapsingremit
demyelin
diseas
cellular
humor
immun
glycoprotein
toxin
cuprizon
lysolecithin
induc
demyelin
anim
denic
et
al
cuprizon
copperchel
agent
oral
administ
induc
demyelin
demyelin
induc
cuprizon
depend
upon
continu
exposur
spontan
remyelin
occur
follow
cessat
treatment
lysolecithin
activ
phospholipas
focal
demyelin
occur
lysolecithin
administ
intracerebr
inject
neither
model
reproduc
inflammatori
compon
demyelin
observ
ms
lesion
therefor
model
use
research
mechan
remyelin
demyelin
produc
cuprizon
model
involv
larg
area
cn
model
amen
biochem
analysi
acut
dissemin
encephalomyel
acut
dissemin
encephalomyel
adem
rare
condit
follow
viral
infect
major
exampl
measl
rubella
varicella
sonnevil
et
al
incid
adem
follow
bacteri
infect
vaccin
also
well
document
patholog
adem
character
multipl
small
perivenular
foci
demyelin
love
et
al
acut
hemorrhag
encephalomyel
sever
form
adem
character
fibrinoid
necrosi
parenchym
vessel
result
multifoc
hemorrhag
typic
leukocytosi
increas
protein
cerebrospin
fluid
consist
compromis
bloodbrain
barrier
demyelin
occur
condit
like
mediat
least
part
immun
mechan
sinc
tcell
sensit
mbp
detect
mani
patient
immunomodulatori
treatment
steroid
intraven
immunoglobulin
typic
administ
addit
support
therapi
control
clinic
trial
assess
efficaci
treatment
progress
multifoc
leukoencephalopathi
pml
demyelin
diseas
caus
infect
oligodendrocyt
jc
papovaviru
peopl
infect
jc
viru
immun
system
prevent
viru
caus
diseas
healthi
individu
howev
peopl
immunosuppress
disord
reticuloendotheli
system
human
immunodefici
viru
infect
therapeut
immunosuppress
autoimmun
diseas
organ
transplant
suscept
tan
koralnick
diseas
progress
rapidli
area
demyelin
larg
show
evid
tissu
destruct
lymphocyt
infiltr
may
present
usual
promin
featur
pml
identifi
number
patient
ms
autoimmun
diseas
treat
monoclon
antibodi
antigen
mediat
cn
immun
cell
surveil
traffick
see
three
major
categori
acquir
peripher
neuropathi
involv
demyelin
paraproteinem
polyneuropathi
syndrom
chronic
inflammatori
demyelin
polyneuropathi
immunemedi
pathogenesi
implic
identif
serum
antibodi
pn
antigen
efficaci
intraven
immunoglobulin
plasma
exchang
treatment
disord
well
experiment
studi
anim
model
like
mani
diseas
involv
primari
demyelin
secondari
axon
injuri
degener
may
critic
factor
perman
disabl
addit
axon
damag
may
primari
patient
immunemedi
peripher
neuropathi
patient
peripher
neuropathi
monoclon
gammopathi
paraproteinemia
expans
clone
plasma
cell
lead
larg
amount
monoclon
antibodi
patient
serum
zivkov
et
al
patient
hematolog
malign
multipl
myeloma
lymphoma
time
diagnosi
premalign
condit
call
monoclon
gammopathi
undetermin
signific
nerv
conduct
studi
show
major
patient
demyelin
neuropathi
western
blot
analysi
demonstr
patient
sera
contain
igm
antibodi
mag
niermeij
et
al
antimag
antibodi
patient
react
carbohydr
epitop
share
myelin
glycoprotein
includ
peripher
myelin
paraglobosid
glycolipid
present
much
larger
amount
matur
pn
cn
patholog
patient
antimag
igm
antibodi
disrupt
compact
myelin
intraperiod
line
sever
anim
model
strongli
suggest
diseas
caus
antibodi
rel
role
potenti
glycoprotein
glycolipid
target
antigen
contribut
patholog
remain
establish
syndrom
gb
includ
wide
spectrum
clinic
phenotyp
initi
descript
monophas
polyneuropathi
frequent
occur
follow
bacteri
viral
infect
character
histolog
segment
demyelin
perivascular
lymphocyt
infiltr
lazzarini
winer
see
also
ch
decad
addit
clinic
phenotyp
identifi
today
gb
spectrum
includ
number
addit
entiti
includ
acut
motor
axon
neuropathi
aman
acut
motor
sensori
axon
neuropathi
bickerstaff
brainstem
enceph
millerfish
syndrom
winer
immunopathogenesi
gb
spectrum
best
understood
aman
hugh
cornblath
kaida
kusunoki
serum
antibodi
gangliosid
includ
identifi
patient
also
anteced
intestin
infect
campylobact
jejuni
subsequ
research
demonstr
crossimmunoreact
serum
antibodi
c
jejuni
lipooligosaccharid
gangliosid
present
myelin
axon
fig
antibodi
elicit
activ
complement
subsequ
nerv
injuri
phagocytosi
aman
repres
best
evid
molecular
mimicri
immunogen
express
anteced
infecti
agent
neural
epitop
pathogenesi
nervou
system
diseas
precis
cellular
local
immunemedi
injuri
identifi
node
ranvier
like
target
addit
studi
demonstr
sera
patient
gb
contain
antibodi
react
strongli
complex
two
gangliosid
individu
gangliosid
kaida
kusunoki
indic
heterodimer
interact
two
gangliosid
presum
within
lipid
raft
produc
new
pathogen
epitop
result
increas
number
patient
gb
antigangliosid
antibodi
identifi
includ
patient
demyelin
identifi
nerv
conduct
studi
presenc
antigangliosid
complex
antibodi
also
correl
clinic
sever
laboratori
diagnost
techniqu
enabl
detect
antigangliosid
complex
antibodi
develop
enabl
highthroughput
analysi
patient
serum
rinaldi
et
al
applic
advanc
like
facilit
research
understand
immunemedi
peripher
neuropathi
well
acquir
immunemedi
diseas
cn
chronic
inflammatori
demyelin
polyneuropathi
cidp
progress
relapsingremit
diseas
durat
mani
month
year
hugh
et
al
histolog
character
onion
bulb
similar
seen
inherit
polyneuropathi
immunemedi
pathogenesi
implic
presenc
lymphocyt
nerv
biopsi
specimen
moder
degre
clinic
improv
patient
follow
immunomodulatori
therapi
pathogenesi
cidp
well
understood
acut
immunemedi
polyneuropathi
current
evid
indic
cellular
immun
respons
play
greater
role
pathogenesi
cidp
paraproteinem
polyneuropathi
gb
term
leukodystrophi
refer
disord
involv
cn
white
matter
comprehens
descript
genet
diseas
involv
cn
white
matter
leukodystrophi
leukoencephalopathi
found
neuropatholog
text
love
et
al
reader
refer
onlin
mendelian
inherit
man
websit
http
wwwncbi
nlmnihgovomim
support
nation
center
biotechnolog
inform
uptod
inform
genet
specif
disord
see
tabl
mani
disord
affect
lipid
metabol
gener
mani
leukodystrophi
also
associ
dysfunct
peripher
nerv
myelin
organ
high
level
lipid
metabol
ch
common
think
leukodystrophi
development
disord
onset
childhood
recognit
adultonset
leukodystrophi
increas
costello
et
al
children
leukodystrophi
typic
present
regress
previous
acquir
motor
skill
person
neurocognit
chang
also
present
may
preced
motor
sign
cognit
neuropsychiatr
symptom
frequent
promin
featur
adult
may
reason
patient
seek
medic
attent
absenc
famili
histori
leukodystrophi
may
consid
initi
symptomat
patient
often
refer
brain
mri
evalu
possibl
acquir
infecti
neoplast
toxic
diseas
set
identif
diffus
symmetr
abnorm
signal
cerebr
white
matter
lead
consider
leukodystrophi
subsequ
solicit
addit
famili
histori
appropri
biochem
andor
genet
test
genet
alter
mani
leukodystrophi
known
possibl
gene
cellbas
therapi
treat
cure
patient
diseas
preliminari
result
demonstr
effect
therapi
depend
upon
earli
presymptomat
diagnosi
intervent
paper
recent
decad
neurochem
abnorm
tissu
patient
differ
newli
describ
leukodystrophi
diagnosi
specif
leukodystrophi
commonli
made
life
patient
autopsi
examin
center
capabl
suitabl
research
analys
tissu
case
magnet
reson
spectroscopi
provid
radiograph
correl
abnorm
neurochem
metabolit
older
research
shown
composit
myelin
genet
determin
disord
normal
specif
alter
reflect
genet
lesion
show
nonspecif
patholog
composit
much
cholesterol
less
cerebrosid
less
phosphatid
ethanolamin
normal
myelin
lazzarini
xlink
adrenoleukodystrophi
preval
leukodystrophi
costello
et
al
biochem
character
accumul
verylongchain
fatti
acid
caus
alter
gene
call
chromosom
gene
encod
peroxisom
membran
protein
member
atpbind
cassett
abc
transport
superfamili
member
superfamili
respons
transport
varieti
molecul
across
cell
membran
exact
mechan
alter
gene
caus
accumul
long
chain
fatti
acid
still
unknown
lazzarini
two
major
clinic
phenotyp
cerebr
leukodystrophi
adrenomyeloneuropathi
minor
patient
present
adren
insuffici
asymptomat
femal
carrier
symptomat
patholog
cerebr
form
uniqu
among
leukodystrophi
mark
perivascular
lymphocyt
inflamm
resembl
inflammatori
demyelin
ms
histolog
observ
demonstr
inflamm
occur
secondari
primari
diseas
oligodendrocyt
two
wellcharacter
leukodystrophi
metachromat
leukodystrophi
krabb
diseas
lysosom
storag
diseas
costello
et
al
ch
diseas
due
genet
alter
singl
enzym
involv
lipid
metabol
preferenti
affect
myelin
metachromat
leukodystrophi
result
genet
alter
arylsulfatas
gene
accumul
sulfatid
metabol
krabb
diseas
alter
galactocylceramidas
gene
enzym
hydrolyz
galactos
ester
bond
present
sever
glycolipid
includ
galactocerebrosid
abund
myelin
galactosylsphingosin
psychosin
galactocerebrosid
accumul
like
oligodendrocyt
die
result
psychosin
toxic
pelizaeusmerzbach
diseas
known
human
leukodystrophi
attribut
defect
gene
encod
myelin
structur
protein
plp
major
patient
duplic
gene
indic
gene
dosag
import
pathogenesi
number
alter
describ
depend
natur
alter
patient
sever
form
term
connat
intermedi
phenotyp
classic
pmd
mild
phenotyp
spastic
paraplegia
noteworthi
mutat
gene
also
caus
peripher
neuropathi
scherer
et
al
probabl
relat
express
low
level
plp
peripher
nerv
see
ch
sever
disord
amino
acid
metabol
aminoacidopathi
associ
myelin
defici
ch
aspartylas
defici
canavan
diseas
phenylketonuria
mapl
syrup
urin
diseas
patholog
disord
demonstr
spongi
myelinopathi
routin
histolog
demonstr
vacuol
white
matter
ultrastructur
analysi
show
split
myelin
sheath
interperiod
line
alexand
diseas
typic
classifi
leukodystrophi
cerebr
white
matter
loss
quit
extens
particularli
infantil
form
research
last
decad
demonstr
case
alexand
diseas
associ
mutat
gfap
gene
quinlan
et
al
mechan
primari
diseas
astrocyt
caus
myelin
patholog
determin
number
genet
diseas
associ
leukodystrophi
rare
pathogenesi
understood
vanish
white
matter
diseas
aicardigoutier
syndrom
associ
alter
protein
express
cell
see
tabl
other
megalencephal
leukoencephalopathi
subcort
cyst
associ
defect
gene
unknown
function
advanc
understand
pathogenesi
diseas
requir
concert
effort
part
research
obtain
post
mortem
tissu
analys
number
inherit
peripher
neuropathi
nomenclatur
classifi
evolv
year
shi
et
al
suter
scherer
lazzarini
scherer
wrabetz
ch
histor
perspect
common
inherit
peripher
neuropathi
divid
two
form
charcotmarietooth
diseas
cmt
larg
basi
electrophysiolog
type
primarili
affect
myelin
type
primarili
affect
axon
number
lesscommon
diseas
limit
peripher
neuropathi
vari
clinic
sever
rang
hereditari
neuropathi
liabil
pressur
palsi
dejerinesotta
syndrom
congenit
hypomyelin
neuropathi
well
genet
syndrom
includ
peripher
neuropathi
compon
scherer
et
al
section
focu
inherit
neuropathi
demyelin
phenotyp
common
form
caus
autosom
domin
mutat
gene
encod
compact
myelin
protein
protein
gene
associ
demyelin
neuropathi
learn
clinic
phenotyp
result
alter
differ
gene
differ
alter
gene
caus
differ
clinic
phenotyp
genet
alter
identifi
inherit
peripher
neuropathi
includ
alter
myelin
structur
protein
transcript
factor
regul
express
myelin
structur
protein
gene
membran
receptor
signal
molecul
mitochondri
protein
emerg
gener
concept
gene
dosag
critic
factor
impact
sever
clinic
phenotyp
support
research
transgen
knockout
anim
model
illustr
import
dosag
myelin
protein
myelin
stabil
see
ch
exampl
usual
due
duplic
gene
onset
second
third
decad
life
character
segment
demyelin
remyelin
onion
bulb
format
hereditari
neuropathi
liabil
pressur
palsi
milder
neuropathi
brought
pressur
trauma
affect
nerv
caus
heterozyg
delet
sever
form
dejerinesotta
syndrom
missens
mutat
transmembran
region
similar
murin
trembler
mutat
see
ch
form
dejerinesotta
syndrom
caus
varieti
mutat
major
glycoprotein
compact
myelin
presum
impair
capac
stabil
intraperiod
andor
major
dens
line
interf
function
signal
transduct
see
ch
form
inherit
neuropathi
affect
myelin
caus
mutat
gene
alter
schwann
cell
protein
local
compact
myelin
exampl
includ
xlink
form
caus
mutat
gap
junction
protein
connexin
local
paranod
loop
incisur
probabl
form
gap
junction
adjac
layer
myelin
membran
recess
form
caus
mutat
periaxin
part
protein
complex
link
extracellular
basal
lamina
actin
cytoskeleton
schwann
cell
domin
form
caus
mutat
zinc
finger
transcript
factor
also
call
krox
recess
form
involv
signal
molecul
myotubularinrel
phosphas
involv
transcript
factor
signal
molecul
demyelin
neuropathi
also
support
import
gene
dosag
exampl
alter
often
result
sever
phenotyp
known
activ
express
number
gene
known
caus
inherit
neuropathi
periaxin
similarli
signal
molecul
particip
numer
cellular
pathway
clear
genet
alter
varieti
schwann
cell
function
caus
myelin
defici
understand
pathogen
mechan
differ
alter
gene
known
involv
inherit
neuropathi
advanc
far
complet
furthermor
case
disord
cn
myelin
becom
increasingli
appar
axon
patholog
degener
often
respons
much
neurolog
impair
inherit
disord
caus
schwann
cellspecif
defect
possibl
due
alter
schwann
cellaxon
interact
ch
much
cn
myelin
mammal
form
rel
restrict
time
period
rapid
develop
last
trimest
prenat
develop
first
year
life
ch
period
larg
portion
brain
metabol
activ
synthet
capac
involv
cerebr
myelinogenesi
vulner
period
appear
time
oligodendrogli
prolifer
differenti
therefor
metabol
insult
vulner
period
may
lead
preferenti
reduct
myelin
format
love
et
al
common
disord
periventricular
leukomalacia
disord
usual
consequ
hypoxicischem
injuri
result
disrupt
oligodendrocyt
matur
patholog
variabl
rang
focal
cavitari
necrosi
gener
cerebr
hypomyelin
specif
nutrit
defici
acquir
toxic
known
caus
patholog
matur
myelin
descript
patholog
mani
disord
found
older
literatur
today
patient
neurolog
symptom
mri
earli
cours
diseas
effect
treatment
initi
stage
result
posit
clinic
outcom
vitamin
defici
result
demyelin
dorsal
later
column
spinal
cord
subacut
degener
spinal
cord
peripher
neuropathi
also
associ
defici
evid
indic
axonopathi
patholog
spinal
cord
lesion
myelinolysi
character
light
microscopi
vacuol
white
matter
electron
microscopi
split
myelin
intraperiod
line
present
defici
less
frequent
due
vitamin
supplement
process
food
clinic
surveil
treatment
patient
risk
primari
defici
vegan
impair
gastric
absorpt
eg
individu
pernici
anemia
central
pontin
myelinolysi
consist
associ
rapid
correct
hyponatremia
low
serum
sodium
patholog
associ
metabol
derang
absenc
hyponatremia
love
et
al
ropper
et
al
preval
diseas
chronic
alcohol
relat
loss
sodium
due
vomit
intestin
sodium
loss
follow
treatment
lactulos
hepat
encephalopathi
acut
patholog
character
disrupt
compact
myelin
intraperiod
line
macrophagemedi
demyelin
necrosi
ensu
absenc
prompt
appropri
treatment
although
pon
characterist
involv
cn
region
contain
intermixtur
myelin
axon
neuron
nuclei
basal
ganglia
later
genicul
nucleu
extern
capsul
cerebellum
also
affect
love
et
al
radiotherapi
chemotherapi
neoplast
diseas
caus
white
matter
patholog
filley
kleinschmidtdemast
love
et
al
endotheli
cell
oligodendrocyt
suscept
damag
agent
pathogenesi
result
leukoencephalopathi
may
multifactori
gener
radiationinduc
leukoencephalopathi
less
common
advanc
stereotact
radiotherapi
number
chemotherapeut
agent
use
treat
cancer
patient
also
implic
white
matter
toxic
notabl
methotrex
often
use
treat
ms
patient
varieti
toxin
associ
leukoencephalopathi
filley
kleinschmidtdemast
love
et
al
poison
trimethyltin
therapeut
use
hexachlorophen
correl
myelinolyt
patholog
lead
also
known
caus
hypomyelin
demyelin
diphtherit
neuropathi
possibl
complic
corynebacterium
diphtheria
infect
character
segment
demyelin
love
et
al
marchiafavabignami
diseas
disord
initi
describ
italian
chronic
alcohol
consum
larg
quantiti
red
wine
character
lesion
corpu
callosum
diagnos
report
recent
literatur
base
upon
mri
unclear
whether
etiolog
toxic
vitamin
defici
archetyp
model
secondari
demyelin
wallerian
degener
see
ch
peripher
nerv
myelin
tract
cn
cut
crush
axon
myelin
distal
segment
degener
demonstr
integr
myelin
sheath
depend
continu
contact
viabl
axon
wallerian
degener
pn
rapid
loss
myelinspecif
lipid
protein
within
week
two
concomit
increas
lysosom
enzym
second
fourth
week
nerv
section
myelin
debri
remov
schwann
cell
macrophag
remyelin
regener
axon
begin
degener
cn
myelin
much
slower
process
pn
take
place
primarili
within
macrophagesmicroglia
within
myelinsynthes
cell
pn
secondari
demyelin
occur
varieti
acquir
genet
cn
disord
initi
affect
neuron
includ
mechan
trauma
infarct
tumor
motor
neuron
diseas
sphingolipidos
taysach
diseas
gener
gangliosidosi
niemannpick
diseas
see
ch
isol
myelin
diseas
usual
nonspecif
patholog
type
discuss
earlier
context
inherit
primari
demyelin
disord
capac
remyelin
depend
upon
presenc
recept
axon
suffici
myelinform
cell
much
chapter
consid
biochem
cell
biolog
mechan
myelin
loss
capac
nervou
tissu
repair
damag
also
import
factor
eventu
clinic
outcom
disord
affect
myelin
myelin
alway
degener
secondari
axon
degener
capac
remyelin
set
depend
upon
success
regener
axon
much
success
pn
cn
motor
sensori
neuron
extend
pn
regener
success
schwann
cell
rapidli
prolifer
form
new
myelin
addit
factor
affect
capac
myelin
repair
primari
diseas
myelin
import
natur
persist
pathogen
insult
exampl
demyelin
mice
treat
cuprizon
rapidli
revers
administr
toxin
stop
success
remyelin
acquir
immunemedi
peripher
neuropathi
also
occur
treatment
inflammatori
pathogenesi
success
similarli
genet
diseas
gene
cellbas
therapi
shown
promis
intervent
take
place
patient
demonstr
symptom
diseas
number
barrier
effect
remyelin
ms
like
pn
remyelin
depend
upon
product
new
myelin
cell
franklin
ffrenchconst
oligodendrocyt
cn
differenti
progenitor
cell
name
express
chondroitin
sulfat
proteoglycan
glia
glia
abil
prolifer
migrat
cell
identifi
within
chronic
ms
lesion
glia
differenti
premyelin
oligodendrocyt
multiprocessbear
cell
express
plp
premyelin
oligodendrocyt
produc
myelin
internod
contact
recept
axon
demyelin
lesion
ms
mani
axon
transect
dystroph
chang
et
al
therefor
even
premyelin
oligodendrocyt
present
ms
lesion
abil
produc
new
myelin
may
inhibit
axon
contact
abnorm
addit
molecul
extracellular
environ
may
inhibit
prolifer
anddifferenti
oligodendrocyt
lineag
cell
franklin
ffrenchconst
final
note
induc
remyelin
could
futil
ongo
demyelin
exce
capac
repair
understand
role
differ
inflammatori
infiltr
associ
molecul
ms
lesion
import
regard
therapi
target
inflamm
aspect
inflamm
may
promot
repair
multipl
therapeut
target
promot
remyelin
cn
franklin
ffrenchconst
includ
increas
number
differenti
oligodendrocyt
lineag
cell
promot
extracellular
environ
promot
myelin
protect
health
demyelin
axon
number
oligodendrocyt
lineag
cell
could
increas
varieti
growth
factor
ch
epiderm
growth
factor
basic
fibroblast
growth
factor
platelet
deriv
growth
factor
ciliari
neurotroph
factor
insulinlik
growth
factor
known
affect
surviv
prolifer
migrat
differenti
oligodendrocyt
progenitor
altern
cell
capac
myelin
could
transplant
specif
lesion
cell
replac
therapi
number
candid
investig
includ
glia
less
differenti
progenitor
cell
cell
stem
cell
properti
number
inhibitor
oligodendrocyt
differenti
identifi
interfer
inhibitor
could
creat
environ
promot
myelin
exampl
oligodendrocyt
membran
protein
inhibit
oligodendrocyt
differenti
myelin
antibodi
promot
remyelin
sever
model
demyelin
increas
awar
substanti
axon
degener
occur
mani
diseas
previous
thought
affect
primarili
myelin
may
account
much
perman
neurolog
deficit
increas
attent
given
therapi
promot
axon
surviv
regener
variou
growth
factor
like
benefici
regard
howev
complic
factor
myelin
contain
number
inhibitor
axon
regener
cao
et
al
see
ch
import
highest
densiti
transect
axon
present
acut
lesion
also
contain
abund
myelin
debri
three
wellcharacter
molecul
nogo
mag
omgp
function
receptor
may
feasibl
block
effect
three
simultan
conclus
therapi
myelin
disord
futur
like
involv
combin
approach
aim
prevent
myelin
loss
time
promot
surviv
regener
remyelin
axon
